Alcon Ag (ALC)

$78.84

-0.73

(-0.92%)▲

Market is closed - opens 7 PM, 26 Apr 2024

Insights on Alcon Ag

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 2.32B → 2.47B (in $), with an average increase of 6.0% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, 169.0M → 427.0M (in $), with an average increase of 34.7% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical, Inc. has given 26.5% return, outperforming this stock by 16.1%

  • Vs ISRG

    In the last 3 years, Intuitive Surgical, Inc. has given 29.3% return, outperforming this stock by 25.7%

Performance

  • $78.04
    $79.00
    $78.84
    downward going graph

    1.01%

    Downside

    Day's Volatility :1.21%

    Upside

    0.2%

    downward going graph
  • $69.44
    $88.23
    $78.84
    downward going graph

    11.92%

    Downside

    52 Weeks Volatility :21.3%

    Upside

    10.64%

    downward going graph

Returns

PeriodAlcon AgSector (Health Care)Index (Russel 2000)
3 Months
3.74%
0.5%
0.0%
6 Months
13.21%
11.7%
0.0%
1 Year
10.42%
6.2%
2.2%
3 Years
3.56%
13.5%
-23.0%

Highlights

Market Capitalization
38.7B
Book Value
$41.81
Dividend Share
0.285
Dividend Yield
0.34%
Earnings Per Share (EPS)
1.96
PE Ratio
39.92
PEG Ratio
4.59
Wall Street Target Price
91.7
Profit Margin
10.3%
Operating Margin TTM
8.12%
Return On Assets TTM
2.17%
Return On Equity TTM
4.83%
Revenue TTM
9.5B
Revenue Per Share TTM
19.18
Quarterly Revenue Growth YOY
8.3%
Gross Profit TTM
4.8B
EBITDA
2.2B
Diluted Eps TTM
1.96
Quarterly Earnings Growth YOY
0.78
EPS Estimate Current Year
3.06
EPS Estimate Next Year
3.49
EPS Estimate Current Quarter
0.68
EPS Estimate Next Quarter
0.76

Analyst Recommendation

Buy
    80%Buy
    9%Hold
    9%Sell
Based on 21 Wall street analysts offering stock ratings for Alcon Ag(by analysts ranked 0 to 5 stars)
Based on 21 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
17
18
16
Hold
2
2
4
Sell
2
1
1

Analyst Forecast

What analysts predicted

Upside of 16.31%

Current $78.84
Target $91.70

Company Financials

FY18Y/Y Change
Revenue
7.2B
↑ 5.32%
Net Income
-227.0M
↓ 188.67%
Net Profit Margin
-3.17%
↓ 6.94%
FY19Y/Y Change
Revenue
7.5B
↑ 4.96%
Net Income
-656.0M
↑ 188.99%
Net Profit Margin
-8.74%
↓ 5.57%
FY20Y/Y Change
Revenue
6.8B
↓ 8.99%
Net Income
-531.0M
↓ 19.05%
Net Profit Margin
-7.77%
↑ 0.97%
FY21Y/Y Change
Revenue
8.3B
↑ 21.34%
Net Income
376.0M
↓ 170.81%
Net Profit Margin
4.54%
↑ 12.31%
FY22Y/Y Change
Revenue
8.7B
↑ 5.14%
Net Income
335.0M
↓ 10.9%
Net Profit Margin
3.84%
↓ 0.7%
FY23Y/Y Change
Revenue
10.1B
↑ 15.77%
Net Income
974.0M
↑ 190.75%
Net Profit Margin
9.65%
↑ 5.81%
Q3 FY22Q/Q Change
Revenue
2.1B
↓ 3.47%
Net Income
116.0M
↓ 21.62%
Net Profit Margin
5.42%
↓ 1.26%
Q4 FY22Q/Q Change
Revenue
2.2B
↑ 1.45%
Net Income
-97.0M
↓ 183.62%
Net Profit Margin
-4.47%
↓ 9.89%
Q1 FY23Q/Q Change
Revenue
2.4B
↑ 8.34%
Net Income
174.0M
↓ 279.38%
Net Profit Margin
7.4%
↑ 11.87%
Q2 FY23Q/Q Change
Revenue
2.4B
↑ 2.98%
Net Income
169.0M
↓ 2.87%
Net Profit Margin
6.98%
↓ 0.42%
Q3 FY23Q/Q Change
Revenue
2.3B
↓ 3.84%
Net Income
204.0M
↑ 20.71%
Net Profit Margin
8.76%
↑ 1.78%
Q4 FY23Q/Q Change
Revenue
2.5B
↑ 6.42%
Net Income
427.0M
↑ 109.31%
Net Profit Margin
17.23%
↑ 8.47%
FY18Y/Y Change
Total Assets
27.1B
↓ 1.19%
Total Liabilities
4.4B
↑ 1.47%
FY19Y/Y Change
Total Assets
27.7B
↑ 2.19%
Total Liabilities
8.4B
↑ 88.83%
FY20Y/Y Change
Total Assets
27.6B
↓ 0.2%
Total Liabilities
8.8B
↑ 5.1%
FY21Y/Y Change
Total Assets
28.0B
↑ 1.45%
Total Liabilities
8.7B
↓ 0.4%
FY22Y/Y Change
Total Assets
29.2B
↑ 4.32%
Total Liabilities
9.5B
↑ 9.02%
FY23Y/Y Change
Total Assets
29.6B
↑ 1.35%
Total Liabilities
9.0B
↓ 5.72%
Q3 FY22Q/Q Change
Total Assets
27.8B
↑ 0.25%
Total Liabilities
8.1B
↓ 0.45%
Q4 FY22Q/Q Change
Total Assets
29.2B
↑ 5.08%
Total Liabilities
9.5B
↑ 16.97%
Q1 FY23Q/Q Change
Total Assets
29.2B
↑ 0.07%
Total Liabilities
9.4B
↓ 1.31%
Q2 FY23Q/Q Change
Total Assets
29.2B
↓ 0.16%
Total Liabilities
9.3B
↓ 1.55%
Q3 FY23Q/Q Change
Total Assets
29.3B
↑ 0.57%
Total Liabilities
9.2B
↓ 0.55%
Q4 FY23Q/Q Change
Total Assets
29.6B
↑ 0.88%
Total Liabilities
9.0B
↓ 2.42%
FY18Y/Y Change
Operating Cash Flow
1.1B
↓ 6.4%
Investing Cash Flow
-1.0B
↑ 47.42%
Financing Cash Flow
-78.0M
↓ 85.53%
FY19Y/Y Change
Operating Cash Flow
920.0M
↓ 19.3%
Investing Cash Flow
-1.0B
↑ 1.0%
Financing Cash Flow
659.0M
↓ 944.87%
FY20Y/Y Change
Operating Cash Flow
823.0M
↓ 10.54%
Investing Cash Flow
-572.0M
↓ 43.42%
Financing Cash Flow
466.0M
↓ 29.29%
FY21Y/Y Change
Operating Cash Flow
1.3B
↑ 63.43%
Investing Cash Flow
-1.2B
↑ 109.44%
Financing Cash Flow
-123.0M
↓ 126.39%
FY22Y/Y Change
Operating Cash Flow
1.2B
↓ 9.52%
Investing Cash Flow
-1.9B
↑ 55.68%
Financing Cash Flow
-8.0M
↓ 93.5%
Q3 FY22Q/Q Change
Operating Cash Flow
402.0M
↓ 0.5%
Investing Cash Flow
-251.0M
↑ 57.86%
Financing Cash Flow
-12.0M
↓ 93.62%
Q4 FY22Q/Q Change
Operating Cash Flow
345.0M
↓ 14.18%
Investing Cash Flow
-852.0M
↑ 239.44%
Financing Cash Flow
281.0M
↓ 2441.67%
Q1 FY23Q/Q Change
Operating Cash Flow
85.9M
↓ 75.1%
Investing Cash Flow
-413.0M
↓ 51.53%
Financing Cash Flow
-21.2M
↓ 107.55%
Q2 FY23Q/Q Change
Operating Cash Flow
325.0M
↑ 278.33%
Investing Cash Flow
-413.0M
↑ 0.0%
Financing Cash Flow
-145.0M
↑ 583.22%
Q3 FY23Q/Q Change
Operating Cash Flow
501.7M
↑ 54.37%
Investing Cash Flow
-152.0M
↓ 63.2%
Financing Cash Flow
12.4M
↓ 108.58%

Technicals Summary

Sell

Neutral

Buy

Alcon Ag is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Alcon Ag
Alcon Ag
-4.59%
13.21%
10.42%
3.56%
35.65%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
-6.16%
43.78%
26.5%
29.27%
115.63%
Resmed Inc.
Resmed Inc.
-5.54%
32.21%
-18.09%
-13.03%
76.47%
Becton, Dickinson And Company
Becton, Dickinson And Company
-4.71%
-9.32%
-10.84%
-10.48%
-3.21%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
-5.16%
12.48%
3.07%
14.2%
197.69%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Alcon Ag
Alcon Ag
39.92
39.92
4.59
3.06
0.05
0.02
0.0
41.81
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
67.57
67.57
7.13
6.28
0.16
0.08
NA
39.37
Resmed Inc.
Resmed Inc.
30.5
30.5
1.75
7.4
0.22
0.11
0.01
30.47
Becton, Dickinson And Company
Becton, Dickinson And Company
53.75
53.75
1.34
12.95
0.05
0.03
0.02
87.68
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
49.52
49.52
6.72
7.62
0.21
0.12
0.0
39.2
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Alcon Ag
Alcon Ag
Buy
$38.7B
35.65%
39.92
10.3%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$133.0B
115.63%
67.57
27.16%
Resmed Inc.
Resmed Inc.
Buy
$27.1B
76.47%
30.5
19.77%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$67.6B
-3.21%
53.75
6.44%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$28.6B
197.69%
49.52
20.12%

Institutional Holdings

  • Liontrust Investment Partners LLP

    0.42%

Corporate Announcements

  • Alcon Ag Dividends September,2024

    In the quarter ending September,2024. Alcon Ag has declared dividend of $0.24

    Read More

Company Information

Alcon is an American Swiss medical company specializing in eye care products with headquarters in Geneva, Switzerland, and incorporated in Fribourg, Switzerland.

Organization
Alcon Ag
Employees
25315
CEO
Mr. F. Michael Ball
Industry
Electronic Equipment/Instruments

Discover More

FAQs